{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:56:45Z","timestamp":1791946605361,"version":"4.3.4"},"reference-count":147,"publisher":"Informa UK Limited","issue":"8","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RHL143545-01A1"],"award-info":[{"award-number":["RHL143545-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/21645515.2021.1885280","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T09:55:13Z","timestamp":1616752513000},"page":"2454-2470","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":46,"title":["A review of the BCG vaccine and other approaches toward tuberculosis eradication"],"prefix":"10.1080","volume":"17","author":[{"given":"Thomas","family":"Cho","sequence":"first","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Khatchadourian","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash","family":"Dara","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuna","family":"Jung","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-1160","authenticated-orcid":false,"given":"Vishwanath","family":"Venketaraman","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA, USA"},{"name":"Graduate College of Biomedical Sciences, Western University of Health Sciences, Pomona, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.009"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"Tran V. Liu J. and Behr M. 2014. BCG Vaccines. Microbiology Spectrum 2(1) pp.mgm2-0028\u20132013","DOI":"10.1128\/microbiolspec.MGM2-0028-2013"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuz006"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0032-2016"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.10.058"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"Zwerling A. Behr M. Verma A. Brewer T. Menzies D. and Pai M. 2011. The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. PLoS Medicine 8(3) p.e1001012","DOI":"10.1371\/journal.pmed.1001012"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-020-02163-0"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"Ritz N. Hanekom W. Robins-Browne R. Britton W. and Curtis N. 2008. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiology Reviews 32(5) pp.821\u2013841","DOI":"10.1111\/j.1574-6976.2008.00118.x"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"Roy A. Eisenhut M. Harris R. Rodrigues L. Sridhar S. Habermann S. Snell L. Mangtani P. Adetifa I. Lalvani A. and Abubakar I. 2014. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ 349 p.g4643","DOI":"10.1136\/bmj.g4643"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmaa030"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13549"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00244-07"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02307"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.3.1718-1724.2006"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1086\/499825"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01317"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.04.006"},{"key":"e_1_3_1_19_1","doi-asserted-by":"crossref","unstructured":"Garly M. Martins C. Bal\u00e9 C. Bald\u00e9 M. Hedegaard K. Gustafson P. Lisse I. Whittle H. and Aaby P. 2003. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. Vaccine 21(21\u201322) pp.2782\u20132790","DOI":"10.1016\/S0264-410X(03)00181-6"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh392"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70412-1"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.09.006"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)03290-0"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000355628"},{"key":"e_1_3_1_25_1","doi-asserted-by":"crossref","unstructured":"Giamarellos-Bourboulis E. Tsilika M. Moorlag S. Antonakos N. Kotsaki A. Dom\u00ednguez-Andr\u00e9s J. Kyriazopoulou E. Gkavogianni T. Adami M. Damoraki G. Koufargyris P. Karageorgos A. Bolanou A. Koenen H. van Crevel R. Droggiti D. Renieris G. Papadopoulos A. and Netea M. 2020. Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly. Cell 183(2) pp.315-323.e9","DOI":"10.1016\/j.cell.2020.08.051"},{"key":"e_1_3_1_26_1","doi-asserted-by":"crossref","unstructured":"Arts R. Moorlag S. Novakovic B. Li Y. Wang S. Oosting M. Kumar V. Xavier R. Wijmenga C. Joosten L. Reusken C. Benn C. Aaby P. Koopmans M. Stunnenberg H. van Crevel R. and Netea M. 2018. BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity. Cell Host & Microbe 23(1) pp.89-100.e5","DOI":"10.1016\/j.chom.2017.12.010"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.12-0179"},{"key":"e_1_3_1_28_1","doi-asserted-by":"crossref","unstructured":"Portevin D. and Young D. 2013. Natural Killer Cell Cytokine Response to M. bovis BCG Is Associated with Inhibited Proliferation Increased Apoptosis and Ultimate Depletion of NKp44+CD56bright Cells. PLoS ONE 8(7) p.e68864","DOI":"10.1371\/journal.pone.0068864"},{"key":"e_1_3_1_29_1","doi-asserted-by":"crossref","unstructured":"Wang D. Gu X. Liu X. Wei S. Wang B. and Fang M. 2018. NK cells inhibit anti-Mycobacterium bovis BCG T cell responses and aggravate pulmonary inflammation in a direct lung infection mouse model. Cellular Microbiology 20(7) p.e12833","DOI":"10.1111\/cmi.12833"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2014.10.005"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902587"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1720"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202870109"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.2.946"},{"key":"e_1_3_1_35_1","doi-asserted-by":"crossref","unstructured":"Kaufmann E. Sanz J. Dunn J. Khan N. Mendon\u00e7a L. Pacis A. Tzelepis F. Pernet E. Dumaine A. Grenier J. Mailhot-L\u00e9onard F. Ahmed E. Belle J. Besla R. Mazer B. King I. Nijnik A. Robbins C. Barreiro L. and Divangahi M. 2018. BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis. Cell 172(1\u20132) pp.176-190.e19","DOI":"10.1016\/j.cell.2017.12.031"},{"key":"e_1_3_1_36_1","doi-asserted-by":"crossref","unstructured":"Cirovic B. de Bree L. Groh L. Blok B. Chan J. van der Velden W. Bremmers M. van Crevel R. H\u00e4ndler K. Picelli S. Schulte-Schrepping J. Klee K. Oosting M. Koeken V. van Ingen J. Li Y. Benn C. Schultze J. Joosten L. Curtis N. Netea M. and Schlitzer A. 2020. BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment. Cell Host & Microbe 28(2) pp.322-334.e5","DOI":"10.1016\/j.chom.2020.05.014"},{"key":"e_1_3_1_37_1","first-page":"53","article-title":"History of BCG Vaccine","volume":"8","author":"Luca S.","year":"2013","unstructured":"Luca, S., Mihaescu, T., 2013. History of BCG Vaccine. Maedica, 8, pp.53\u201358","journal-title":"Maedica"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00394-14"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11060270"},{"key":"e_1_3_1_40_1","doi-asserted-by":"crossref","unstructured":"Balseiro A. Prieto J. \u00c1lvarez V. Lesellier S. Dav\u00e9 D. Salguero F. Sevilla I. Infantes-Lorenzo J. Garrido J. Adriaensen H. Juste R. and Barral M. 2020. Protective Effect of Oral BCG and Inactivated Mycobacterium bovis Vaccines in European Badgers (Meles meles) Experimentally Infected With M. bovis. Frontiers in Veterinary Science 7 p.41","DOI":"10.3389\/fvets.2020.00041"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.06.059"},{"key":"e_1_3_1_42_1","doi-asserted-by":"crossref","unstructured":"Lesellier S. Birch C. Dav\u00e9 D. Dalley D. Gowtage S. Palmer S. McKenna C. Williams G. Ashford R. Weyer U. Beatham S. Coats J. Nunez A. Sanchez-Cordon P. Spiropoulos J. Powell S. Sawyer J. Pascoe J. Hendon-Dunn C. Bacon J. and Chambers M. 2020. Bioreactor-Grown Bacillus of Calmette and Gu\u00e9rin (BCG) Vaccine Protects Badgers against Virulent Mycobacterium bovis When Administered Orally: Identifying Limitations in Baited Vaccine Delivery. Pharmaceutics 12(8) p.782","DOI":"10.3390\/pharmaceutics12080782"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75734-x"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1817-8"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.03.397"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.07.061"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-03514-1"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.8.3317-3327.1997"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.5.1856-1862.1997"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10448-8"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(00)90088-9"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.843"},{"issue":"6","key":"e_1_3_1_53_1","first-page":"377","article-title":"Immunization of HIV-Infected Adults With a Three-Dose Series of Inactivated Mycobacterium vaccae","volume":"313","author":"Marsh B.","year":"1997","unstructured":"Marsh, B., Von Reyn, C., Arbeit, R. and Morin, P., 1997. Immunization of HIV-Infected Adults With a Three-Dose Series of Inactivated Mycobacterium vaccae. The American Journal of the Medical Sciences, 313(6), pp.377\u2013383","journal-title":"The American Journal of the Medical Sciences"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1086\/515024"},{"key":"e_1_3_1_55_1","doi-asserted-by":"crossref","unstructured":"Hansen S. Zak D. Xu G. Ford J. Marshall E. Malouli D. Gilbride R. Hughes C. Ventura A. Ainslie E. Randall K. Selseth A. Rundstrom P. Herlache L. Lewis M. Park H. Planer S. Turner J. Fischer M. Armstrong C. Zweig R. Valvo J. Braun J. Shankar S. Lu L. Sylwester A. Legasse A. Messerle M. Jarvis M. Amon L. Aderem A. Alter G. Laddy D. Stone M. Bonavia A. Evans T. Axthelm M. Fr\u00fch K. Edlefsen P. and Picker L. 2018. Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine. Nature Medicine 24(2) pp.130\u2013143","DOI":"10.1038\/nm.4473"},{"key":"e_1_3_1_56_1","doi-asserted-by":"crossref","unstructured":"Stylianou E. Harrington-Kandt R. Beglov J. Bull N. Pinpathomrat N. Swarbrick G. Lewinsohn D. Lewinsohn D. and McShane H. 2018. Identification and Evaluation of Novel Protective Antigens for the Development of a Candidate Tuberculosis Subunit Vaccine. Infection and Immunity 86(7) pp.e00014\u201318","DOI":"10.1128\/IAI.00014-18"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2010.00660.x"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2014.03.005"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.03.072"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.094"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.135"},{"key":"e_1_3_1_62_1","doi-asserted-by":"crossref","unstructured":"Reither K. Katsoulis L. Beattie T. Gardiner N. Lenz N. Said K. Mfinanga E. Pohl C. Fielding K. Jeffery H. Kagina B. Hughes E. Scriba T. Hanekom W. Hoff S. Bang P. Kromann I. Daubenberger C. Andersen P. and Churchyard G. 2014. Safety and Immunogenicity of H1\/IC31\u00ae an Adjuvanted TB Subunit Vaccine in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells\/mm3: A Phase II Multi-Centre Double-Blind Randomized Placebo-Controlled Trial. PLoS ONE 9(12) p.e114602","DOI":"10.1371\/journal.pone.0114602"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.023"},{"key":"e_1_3_1_64_1","doi-asserted-by":"crossref","unstructured":"Idoko O. Owolabi O. Owiafe P. Moris P. Odutola A. Bollaerts A. Ogundare E. Jongert E. Demoiti\u00e9 M. Ofori-Anyinam O. and Ota M. 2014. Safety and immunogenicity of the M72\/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: An open-label randomized controlled trial. Tuberculosis 94(6) pp.564\u2013578","DOI":"10.1016\/j.tube.2014.07.001"},{"key":"e_1_3_1_65_1","doi-asserted-by":"crossref","unstructured":"Kumarasamy N. Poongulali S. Bollaerts A. Moris P. Beulah F. Ayuk L. Demoiti\u00e9 M. Jongert E. and Ofori-Anyinam O. 2016. A Randomized Controlled Safety and Immunogenicity Trial of the M72\/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults. Medicine 95(3) p.e2459","DOI":"10.1097\/MD.0000000000002459"},{"key":"e_1_3_1_66_1","doi-asserted-by":"crossref","unstructured":"Gillard P. Yang P. Danilovits M. Su W. Cheng S. Pehme L. Bollaerts A. Jongert E. Moris P. Ofori-Anyinam O. Demoiti\u00e9 M. and Castro M. 2016. Safety and immunogenicity of the M72\/AS01 E candidate tuberculosis vaccine in adults with tuberculosis: A phase II randomised study. Tuberculosis 100 pp.118\u2013127","DOI":"10.1016\/j.tube.2016.07.005"},{"key":"e_1_3_1_67_1","doi-asserted-by":"crossref","unstructured":"Van Der Meeren O. Hatherill M. Nduba V. Wilkinson R. Muyoyeta M. Van Brakel E. Ayles H. Henostroza G. Thienemann F. Scriba T. Diacon A. Blatner G. Demoiti\u00e9 M. Tameris M. Malahleha M. Innes J. Hellstr\u00f6m E. Martinson N. Singh T. Akite E. Khatoon Azam A. Bollaerts A. Ginsberg A. Evans T. Gillard P. and Tait D. 2018. Phase 2b Controlled Trial of M72\/AS01EVaccine to Prevent Tuberculosis. New England Journal of Medicine 379(17) pp.1621\u20131634","DOI":"10.1056\/NEJMoa1803484"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00094-08"},{"key":"e_1_3_1_69_1","doi-asserted-by":"crossref","unstructured":"Vilaplana C. Gil O. C\u00e1ceres N. Pinto S. D\u00edaz J. and Cardona P. 2011. Prophylactic Effect of a Therapeutic Vaccine against TB Based on Fragments of Mycobacterium tuberculosis. PLoS ONE 6(5) p.e20404","DOI":"10.1371\/journal.pone.0020404"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00894"},{"key":"e_1_3_1_71_1","doi-asserted-by":"crossref","unstructured":"Cardona P. Amat I. Gordillo S. Arcos V. Guirado E. D\u00edaz J. Vilaplana C. Tapia G. and Ausina V. 2005. Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis. Vaccine 23(11) pp.1393\u20131398","DOI":"10.1016\/j.vaccine.2004.09.008"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.09.134"},{"key":"e_1_3_1_73_1","doi-asserted-by":"crossref","unstructured":"Nell A. D\u2019lom E. Bouic P. Sabat\u00e9 M. Bosser R. Picas J. Amat M. Churchyard G. and Cardona P. 2014. Safety Tolerability and Immunogenicity of the Novel Antituberculous Vaccine RUTI: Randomized Placebo-Controlled Phase II Clinical Trial in Patients with Latent Tuberculosis Infection. PLoS ONE 9(2) p.e89612","DOI":"10.1371\/journal.pone.0089612"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00015-11"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.01.058"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409716102"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/npjvaccines.2016.12"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.066"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-09119-y"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.905746"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24617"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu347"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir592"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2016.03.005"},{"key":"e_1_3_1_85_1","doi-asserted-by":"crossref","unstructured":"Loxton A. Knaul J. Grode L. Gutschmidt A. Meller C. Eisele B. Johnstone H. van der Spuy G. Maertzdorf J. Kaufmann S. Hesseling A. Walzl G. and Cotton M. 2016. Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa. Clinical and Vaccine Immunology 24(2) pp.e00439\u201316","DOI":"10.1128\/CVI.00439-16"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100313"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714021"},{"key":"e_1_3_1_88_1","doi-asserted-by":"crossref","unstructured":"Barreto M. Pereira S. Pilger D. Cruz A. Cunha S. Sant\u2019Anna C. Ichihara M. Genser B. and Rodrigues L. 2011. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: Second report of the BCG-REVAC cluster-randomised trial. Vaccine 29(31) pp.4875\u20134877","DOI":"10.1016\/j.vaccine.2011.05.023"},{"key":"e_1_3_1_89_1","doi-asserted-by":"crossref","unstructured":"Rodrigues L. Pereira S. Cunha S. Genser B. Ichihara M. de Brito S. Hijjar M. Cruz A. Sant'Anna C. Bierrenbach A. Barreto M. and Dourado I. 2005. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. The Lancet 366(9493) pp.1290\u20131295","DOI":"10.1016\/S0140-6736(05)67145-0"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00287-09"},{"key":"e_1_3_1_91_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00275-12"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.07.055"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.10.6357"},{"key":"e_1_3_1_94_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3770"},{"key":"e_1_3_1_95_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00004-07"},{"key":"e_1_3_1_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.048"},{"key":"e_1_3_1_97_1","doi-asserted-by":"crossref","unstructured":"Tkachuk A. Gushchin V. Potapov V. Demidenko A. Lunin V. and Gintsburg A. 2017. Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models. PLOS ONE 12(4) p.e0176784","DOI":"10.1371\/journal.pone.0176784"},{"key":"e_1_3_1_98_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7040166"},{"key":"e_1_3_1_99_1","doi-asserted-by":"crossref","unstructured":"Aagaard C. Hoang T. Izzo A. Billeskov R. Troudt J. Arnett K. Keyser A. Elvang T. Andersen P. and Dietrich J. 2009. Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4\/IC31\u00ae against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose. PLoS ONE 4(6) p.e5930","DOI":"10.1371\/journal.pone.0005930"},{"key":"e_1_3_1_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.05.036"},{"key":"e_1_3_1_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.01.055"},{"key":"e_1_3_1_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2285"},{"key":"e_1_3_1_103_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46252"},{"key":"e_1_3_1_104_1","doi-asserted-by":"crossref","unstructured":"Billeskov R. Tan E. Cang M. Abalos R. Burgos J. Pedersen B. Christensen D. Agger E. and Andersen P. 2016. Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis. PLOS ONE 11(8) p.e0161217","DOI":"10.1371\/journal.pone.0161217"},{"key":"e_1_3_1_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.051"},{"key":"e_1_3_1_106_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201802-0366OC"},{"key":"e_1_3_1_107_1","doi-asserted-by":"crossref","unstructured":"Bertholet S. Ireton G. Ordway D. Windish H. Pine S. Kahn M. Phan T. Orme I. Vedvick T. Baldwin S. Coler R. and Reed S. 2010. A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis. Science Translational Medicine 2(53) pp.53ra74","DOI":"10.1126\/scitranslmed.3001094"},{"key":"e_1_3_1_108_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102696"},{"key":"e_1_3_1_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52146-0"},{"key":"e_1_3_1_110_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00458-15"},{"key":"e_1_3_1_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0057-5"},{"key":"e_1_3_1_112_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00372-14"},{"key":"e_1_3_1_113_1","doi-asserted-by":"crossref","unstructured":"Lahey T. Laddy D. Hill K. Schaeffer J. Hogg A. Keeble J. Dagg B. Ho M. Arbeit R. and von Reyn C. 2016. Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis. PLOS ONE 11(12) p.e0168521","DOI":"10.1371\/journal.pone.0168521"},{"key":"e_1_3_1_114_1","doi-asserted-by":"crossref","unstructured":"von Reyn C. Lahey T. Arbeit R. Landry B. Kailani L. Adams L. Haynes B. Mackenzie T. Wieland-Alter W. Connor R. Tvaroha S. Hokey D. Ginsberg A. and Waddell R. 2017. Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized controlled trial of DAR-901. PLOS ONE 12(5) p.e0175215","DOI":"10.1371\/journal.pone.0175215"},{"key":"e_1_3_1_115_1","doi-asserted-by":"crossref","unstructured":"Masonou T. Hokey D. Lahey T. Halliday A. Berrocal-Almanza L. Wieland-Alter W. Arbeit R. Lalvani A. and von Reyn C. 2019. CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized placebo-controlled trial. PLOS ONE 14(5) p.e0217091","DOI":"10.1371\/journal.pone.0217091"},{"key":"e_1_3_1_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.03.017"},{"key":"e_1_3_1_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2015.10.010"},{"key":"e_1_3_1_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30251-6"},{"key":"e_1_3_1_119_1","doi-asserted-by":"crossref","unstructured":"Taranc\u00f3n R. Dom\u00ednguez-Andr\u00e9s J. Uranga S. Ferreira A. Groh L. Domenech M. Gonz\u00e1lez-Camacho F. Riksen N. Aguilo N. Yuste J. Mart\u00edn C. and Netea M. 2020. New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia. PLOS Pathogens 16(4) p.e1008404","DOI":"10.1371\/journal.ppat.1008404"},{"key":"e_1_3_1_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13567-019-0702-7"},{"key":"e_1_3_1_121_1","doi-asserted-by":"crossref","unstructured":"Verreck F. Vervenne R. Kondova I. van Kralingen K. Remarque E. Braskamp G. van der Werff N. Kersbergen A. Ottenhoff T. Heidt P. Gilbert S. Gicquel B. Hill A. Martin C. McShane H. and Thomas A. 2009. MVA.85A Boosting of BCG and an Attenuated phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques. PLoS ONE 4(4) p.e5264","DOI":"10.1371\/journal.pone.0005264"},{"key":"e_1_3_1_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00435-X"},{"key":"e_1_3_1_123_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix030"},{"key":"e_1_3_1_124_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01339"},{"key":"e_1_3_1_125_1","doi-asserted-by":"crossref","unstructured":"Saini V. Raghuvanshi S. Talwar G. Ahmed N. Khurana J. Hasnain S. Tyagi A. and Tyagi A. 2009. Polyphasic Taxonomic Analysis Establishes Mycobacterium indicus pranii as a Distinct Species. PLoS ONE 4(7) p.e6263","DOI":"10.1371\/journal.pone.0006263"},{"key":"e_1_3_1_126_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1991.tb01517.x"},{"key":"e_1_3_1_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2014.05.006"},{"key":"e_1_3_1_128_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00526-08"},{"key":"e_1_3_1_129_1","doi-asserted-by":"crossref","unstructured":"Singh B. Saqib M. Gupta A. Kumar P. and Bhaskar S. 2017. Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages. PLOS ONE 12(12) p.e0189606","DOI":"10.1371\/journal.pone.0189606"},{"key":"e_1_3_1_130_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02359"},{"key":"e_1_3_1_131_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4157-2"},{"key":"e_1_3_1_132_1","doi-asserted-by":"crossref","unstructured":"Gupta A. Ahmad F. Ahmad F. Gupta U. Natarajan M. Katoch V. and Bhaskar S. 2012. Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung. PLoS ONE 7(7) p.e39215","DOI":"10.1371\/journal.pone.0039215"},{"key":"e_1_3_1_133_1","doi-asserted-by":"publisher","DOI":"10.2741\/1292"},{"key":"e_1_3_1_134_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2000.00054.x"},{"key":"e_1_3_1_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2019.100141"},{"key":"e_1_3_1_136_1","doi-asserted-by":"crossref","unstructured":"Dicks M. Spencer A. Edwards N. Wadell G. Bojang K. Gilbert S. Hill A. and Cottingham M. 2012. A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity. PLoS ONE 7(7) p.e40385","DOI":"10.1371\/journal.pone.0040385"},{"key":"e_1_3_1_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.017"},{"key":"e_1_3_1_138_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9949-3"},{"key":"e_1_3_1_139_1","doi-asserted-by":"crossref","unstructured":"Kumarasamy N. Poongulali S. Beulah F. Akite E. Ayuk L. Bollaerts A. Demoiti\u00e9 M. Jongert E. Ofori-Anyinam O. and Van Der Meeren O. 2018. Long-term safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in HIV-positive and -negative Indian adults. Medicine 97(45) p.e13120","DOI":"10.1097\/MD.0000000000013120"},{"key":"e_1_3_1_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2006.01.024"},{"key":"e_1_3_1_141_1","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201000125"},{"key":"e_1_3_1_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.053"},{"key":"e_1_3_1_143_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01147"},{"key":"e_1_3_1_144_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00517-06"},{"key":"e_1_3_1_145_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200910-1484OC"},{"key":"e_1_3_1_146_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.10.114"},{"key":"e_1_3_1_147_1","doi-asserted-by":"crossref","unstructured":"Arbues A. Aguilo J. Gonzalo-Asensio J. Marinova D. Uranga S. Puentes E. Fernandez C. Parra A. Cardona P. Vilaplana C. Ausina V. Williams A. Clark S. Malaga W. Guilhot C. Gicquel B. and Martin C. 2013. Construction characterization and preclinical evaluation of MTBVAC the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials. Vaccine 31(42) pp.4867\u20134873","DOI":"10.1016\/j.vaccine.2013.07.051"},{"key":"e_1_3_1_148_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16085"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1885280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T09:59:15Z","timestamp":1709287155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1885280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":147,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/21645515.2021.1885280"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1885280","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-11-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}